Drug information for ROSIGLITAZONE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
TABLET; ORAL 2MG Tentative Approval   ROSIGLITAZONE MALEATE rosiglitazone DR REDDYS LABS INC 76748
TABLET; ORAL 4MG Tentative Approval   ROSIGLITAZONE MALEATE rosiglitazone DR REDDYS LABS INC   "
TABLET; ORAL 8MG Tentative Approval   ROSIGLITAZONE MALEATE rosiglitazone DR REDDYS LABS INC   "
TABLET; ORAL 2MG Tentative Approval   ROSIGLITAZONE MALEATE rosiglitazone WATSON LABS 78023
TABLET; ORAL 4MG Tentative Approval   ROSIGLITAZONE MALEATE rosiglitazone WATSON LABS   "
TABLET; ORAL 8MG Tentative Approval   ROSIGLITAZONE MALEATE rosiglitazone WATSON LABS   "

Drug Adverse Effects information for ROSIGLITAZONE

Role code Indications Reaction # Reports
PS DIABETES MELLITUS ANAEMIA 2
PS DIABETES MELLITUS ATRIAL FIBRILLATION 1
PS DIABETES MELLITUS CARDIAC DISORDER 1
PS DIABETES MELLITUS CARDIAC FAILURE CONGESTIVE 2
PS DIABETES MELLITUS CARDIOVASCULAR DISORDER 1
PS DIABETES MELLITUS CEREBROVASCULAR ACCIDENT 1
PS DIABETES MELLITUS CORONARY ARTERY DISEASE 1
PS DIABETES MELLITUS DYSPNOEA 1
PS DIABETES MELLITUS FEMUR FRACTURE 1
PS DIABETES MELLITUS HYPERHIDROSIS 1
PS DIABETES MELLITUS HYPERTENSION 1
PS DIABETES MELLITUS LUNG DISORDER 1
PS DIABETES MELLITUS MYOCARDIAL INFARCTION 1
PS DIABETES MELLITUS OEDEMA 1
PS DIABETES MELLITUS OEDEMA PERIPHERAL 1
PS DIABETES MELLITUS OSTEOPOROSIS 1
PS DIABETES MELLITUS PALLOR 1
PS DIABETES MELLITUS THROMBOSIS 1
PS TYPE 2 DIABETES MELLITUS BUNDLE BRANCH BLOCK RIGHT 1
PS TYPE 2 DIABETES MELLITUS CARDIAC DISORDER 1
PS TYPE 2 DIABETES MELLITUS CONDITION AGGRAVATED 1
PS TYPE 2 DIABETES MELLITUS CORONARY ARTERY DISEASE 1
PS TYPE 2 DIABETES MELLITUS DEATH 1
PS TYPE 2 DIABETES MELLITUS LIVER DISORDER 1
PS TYPE 2 DIABETES MELLITUS MYOCARDIAL INFARCTION 1
PS TYPE 2 DIABETES MELLITUS MYOCARDIAL ISCHAEMIA 1
PS TYPE 2 DIABETES MELLITUS SURGERY 1
SS ARTHRALGIA BLOOD CREATININE INCREASED 1
SS ARTHRALGIA BLOOD UREA INCREASED 1
SS ARTHRALGIA DEHYDRATION 1
SS ARTHRALGIA ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1
SS ARTHRALGIA HYPERKALAEMIA 1
SS PRODUCT USED FOR UNKNOWN INDICATION BLADDER CANCER 2
SS PRODUCT USED FOR UNKNOWN INDICATION DEEP VEIN THROMBOSIS 2
SS PRODUCT USED FOR UNKNOWN INDICATION FATIGUE 2
SS PRODUCT USED FOR UNKNOWN INDICATION METASTASES TO LIVER 2
SS PRODUCT USED FOR UNKNOWN INDICATION METASTASES TO LUNG 2
SS PRODUCT USED FOR UNKNOWN INDICATION METASTASES TO PERITONEUM 2
SS PRODUCT USED FOR UNKNOWN INDICATION NEOPLASM PROGRESSION 2
SS TYPE 2 DIABETES MELLITUS CARDIAC FAILURE CONGESTIVE 2
SS TYPE 2 DIABETES MELLITUS HEART INJURY 2
SS URINARY TRACT INFECTION BLOOD CREATININE INCREASED 1
SS URINARY TRACT INFECTION BLOOD UREA INCREASED 1
SS URINARY TRACT INFECTION DEHYDRATION 1
SS URINARY TRACT INFECTION ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1
SS URINARY TRACT INFECTION HYPERKALAEMIA 1
C ARTHRALGIA ASTHENIA 1
C ARTHRALGIA BLOOD CREATININE INCREASED 1
C ARTHRALGIA ELECTROCARDIOGRAM ABNORMAL 1
C ARTHRALGIA HYPERHIDROSIS 1
C ARTHRALGIA HYPERKALAEMIA 1
C ARTHRALGIA NAUSEA 1
C BLOOD CORTICOTROPHIN INCREASED ANOSMIA 2
C BLOOD CORTICOTROPHIN INCREASED AREFLEXIA 2
C BLOOD CORTICOTROPHIN INCREASED ASPIRATION 2
C BLOOD CORTICOTROPHIN INCREASED BACK PAIN 2
C BLOOD CORTICOTROPHIN INCREASED BLOOD CORTICOTROPHIN INCREASED 2
C BLOOD CORTICOTROPHIN INCREASED CORTISOL FREE URINE INCREASED 2
C BLOOD CORTICOTROPHIN INCREASED CRANIAL NERVE PARALYSIS 1
C BLOOD CORTICOTROPHIN INCREASED CUSHING'S SYNDROME 1
C BLOOD CORTICOTROPHIN INCREASED DEATH 2
C BLOOD CORTICOTROPHIN INCREASED DYSPHAGIA 3
C BLOOD CORTICOTROPHIN INCREASED EYE MOVEMENT DISORDER 2
C BLOOD CORTICOTROPHIN INCREASED FATIGUE 2
C BLOOD CORTICOTROPHIN INCREASED HEADACHE 2
C BLOOD CORTICOTROPHIN INCREASED HEMIANOPIA 2
C BLOOD CORTICOTROPHIN INCREASED HYPERGLYCAEMIA 3
C BLOOD CORTICOTROPHIN INCREASED HYPERTENSION 1
C BLOOD CORTICOTROPHIN INCREASED HYPOAESTHESIA 2
C BLOOD CORTICOTROPHIN INCREASED MEMORY IMPAIRMENT 2
C BLOOD CORTICOTROPHIN INCREASED METASTASES TO BONE 3
C BLOOD CORTICOTROPHIN INCREASED METASTASES TO SPINE 1
C BLOOD CORTICOTROPHIN INCREASED MUSCULAR WEAKNESS 2
C BLOOD CORTICOTROPHIN INCREASED NEOPLASM PROGRESSION 2
C BLOOD CORTICOTROPHIN INCREASED NEUROENDOCRINE TUMOUR 1
C BLOOD CORTICOTROPHIN INCREASED PITUITARY TUMOUR 1
C BLOOD CORTICOTROPHIN INCREASED POST PROCEDURAL COMPLICATION 1
C BLOOD CORTICOTROPHIN INCREASED PUPILLARY REFLEX IMPAIRED 2
C BLOOD CORTICOTROPHIN INCREASED SECONDARY HYPOGONADISM 1
C BLOOD CORTICOTROPHIN INCREASED SKIN HYPERPIGMENTATION 2
C BLOOD CORTICOTROPHIN INCREASED SMALL CELL CARCINOMA 1
C HYPERTENSION COLONIC POLYP 1
C HYPERTENSION DIABETES MELLITUS 1
C HYPERTENSION DIVERTICULUM INTESTINAL 1
C HYPERTENSION GAIT DISTURBANCE 1
C HYPERTENSION THYROID CANCER 1
C HYPERTENSION THYROID NEOPLASM 1
C HYPERTENSION VERTIGO 1
C MULTIPLE SCLEROSIS COLONIC POLYP 1
C MULTIPLE SCLEROSIS DIABETES MELLITUS 1
C MULTIPLE SCLEROSIS DIVERTICULUM INTESTINAL 1
C MULTIPLE SCLEROSIS GAIT DISTURBANCE 1
C MULTIPLE SCLEROSIS THYROID CANCER 1
C MULTIPLE SCLEROSIS THYROID NEOPLASM 1
C MULTIPLE SCLEROSIS VERTIGO 1
C PRODUCT USED FOR UNKNOWN INDICATION CRANIAL NERVE PARALYSIS 2
C PRODUCT USED FOR UNKNOWN INDICATION CUSHING'S SYNDROME 2
C PRODUCT USED FOR UNKNOWN INDICATION DYSPHAGIA 2
C PRODUCT USED FOR UNKNOWN INDICATION HYPERGLYCAEMIA 2
C PRODUCT USED FOR UNKNOWN INDICATION HYPERTENSION 2
C PRODUCT USED FOR UNKNOWN INDICATION METASTASES TO BONE 2
C PRODUCT USED FOR UNKNOWN INDICATION METASTASES TO SPINE 2
C PRODUCT USED FOR UNKNOWN INDICATION NEUROENDOCRINE TUMOUR 2
C PRODUCT USED FOR UNKNOWN INDICATION PITUITARY TUMOUR 2
C PRODUCT USED FOR UNKNOWN INDICATION POST PROCEDURAL COMPLICATION 2
C PRODUCT USED FOR UNKNOWN INDICATION SECONDARY HYPOGONADISM 2
C PRODUCT USED FOR UNKNOWN INDICATION SMALL CELL CARCINOMA 2
C SMALL CELL CARCINOMA ANOSMIA 4
C SMALL CELL CARCINOMA AREFLEXIA 4
C SMALL CELL CARCINOMA ASPIRATION 4
C SMALL CELL CARCINOMA BACK PAIN 4
C SMALL CELL CARCINOMA BLOOD CORTICOTROPHIN INCREASED 4
C SMALL CELL CARCINOMA CORTISOL FREE URINE INCREASED 4
C SMALL CELL CARCINOMA DEATH 4
C SMALL CELL CARCINOMA DYSPHAGIA 4
C SMALL CELL CARCINOMA EYE MOVEMENT DISORDER 4
C SMALL CELL CARCINOMA FATIGUE 4
C SMALL CELL CARCINOMA HEADACHE 4
C SMALL CELL CARCINOMA HEMIANOPIA 4
C SMALL CELL CARCINOMA HYPERGLYCAEMIA 4
C SMALL CELL CARCINOMA HYPOAESTHESIA 4
C SMALL CELL CARCINOMA MEMORY IMPAIRMENT 4
C SMALL CELL CARCINOMA METASTASES TO BONE 4
C SMALL CELL CARCINOMA MUSCULAR WEAKNESS 4
C SMALL CELL CARCINOMA NEOPLASM PROGRESSION 4
C SMALL CELL CARCINOMA PUPILLARY REFLEX IMPAIRED 4
C SMALL CELL CARCINOMA SKIN HYPERPIGMENTATION 4
C TYPE 2 DIABETES MELLITUS COLONIC POLYP 1
C TYPE 2 DIABETES MELLITUS DIABETES MELLITUS 1
C TYPE 2 DIABETES MELLITUS DIVERTICULUM INTESTINAL 1
C TYPE 2 DIABETES MELLITUS GAIT DISTURBANCE 1
C TYPE 2 DIABETES MELLITUS THYROID CANCER 1
C TYPE 2 DIABETES MELLITUS THYROID NEOPLASM 1
C TYPE 2 DIABETES MELLITUS VERTIGO 1
C URINARY TRACT INFECTION ASTHENIA 1
C URINARY TRACT INFECTION BLOOD CREATININE INCREASED 1
C URINARY TRACT INFECTION ELECTROCARDIOGRAM ABNORMAL 1
C URINARY TRACT INFECTION HYPERHIDROSIS 1
C URINARY TRACT INFECTION HYPERKALAEMIA 1
C URINARY TRACT INFECTION NAUSEA 1
Ads by Google